PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsSenior IVF doctor declaims 'serious health risk' of ovarian stimulation

BioNews

Senior IVF doctor declaims 'serious health risk' of ovarian stimulation

Published 28 February 2013 posted in News and appears in BioNews 657

Author

Dr Greg Ball

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.

A senior IVF doctor has voiced concerns over health risks to women in IVF treatments that are commonly practiced by UK clinics...

A senior IVF doctor has voiced concerns over health risks to women in IVF treatments that are commonly practiced by UK clinics.

Ovarian stimulation - where drugs are used to stimulate the production of eggs - is frequently employed during IVF in the UK. But the technique carries a health risk and can engender serious or even fatal complications. Some studies suggest that embryos produced from eggs released during ovarian stimulation carry a higher risk of abnormalities.

These concerns were discussed at the conference of the International Society for Mild Approaches in Assisted Reproduction (ISMAAR) in Copenhagen. Professor Geeta Nargund, President of ISMAAR and Head of Reproductive Medicine services at St George's University Hospital, London, told the conference: 'High-dose stimulation can have distressing side effects on the woman, the most serious of which is called ovarian hyper-stimulation syndrome (OHSS). A recent confidential inquiry into maternal deaths in the UK showed that OHSS was now one of the biggest causes of maternal mortality in England and Wales. There is no doubt that women subjected to this kind of stimulation are at serious health risk'.

The Independent reported figures obtained under the Freedom of Information Act from the Human Fertilisation and Embryology Authority (HFEA). Thirty thousand cases of OHSS were recorded between 1991 and 2007, with symptoms ranging from chest pains and shortness of breath to kidney failure.

Professor Nargund, who in a recent slot on Channel 4's 4Thought TV programme described herself as 'a campaigner for women's health and safety in fertility treatment', is supported by others in the field. Professor Ian Cooke, Chief Executive of the Low Cost IVF Foundation told the Independent: 'We are over-stimulating women, driving the cost up and the complications up. The first aim should be to reduce complications'.

The mild IVF technique uses less harmful drugs to stimulate the ovaries, producing fewer eggs and having lower pregnancy rates per cycle. However there is a quicker recovery time compared to standard IVF with treatment able to be repeated within a month. Professor Nargund told the conference: 'We could double the number of patients treated at no extra cost and the complications would be less'.

Fertility clinics in Canada, Japan, South Korea, Scandinavia and several European countries have adopted the mild IVF approach, while in the US and the UK high-dose IVF is preferred.

Nonetheless, there are doubts regarding the success rates of mild IVF. Susan Seenan, deputy chief executive of the Infertility Network UK said: 'The first thing women will want to know is: what are their chances of a baby with mild IVF? If patients have to undergo multiple cycles it might mean more disappointment and upset'.

A spokesman for the HFEA commented: 'There is currently no data which we hold that is an accurate marker of poor clinical practice or is a predictor for the likelihood of a patient experiencing OHSS. The HFEA continues to monitor this research'.

Related Articles

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
7 April 2014 • 2 minutes read

Fertility drugs may not increase breast cancer risk

by Dr Lux Fatimathas

Fertility drugs used to stimulate ovulation did not increase the chances of breast cancer for most women in a long-term study of around 10,000 women in the USA...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
5 March 2013 • 1 minute read

IVF slightly increases risk of adverse outcomes for mother and baby, report says

by James Brooks

Use of assisted reproductive technologies like IVF carry with them an increased risk of complications for mother and child, a report from the Royal College of Obstetricians and Gynaecologists highlights...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
14 November 2012 • 2 minutes read

Ovarian stimulation linked to egg abnormalities in older mothers

by Dr Lux Fatimathas

European researchers have linked ovarian stimulation in women aged over 35 to increased chromosomal abnormalities. Genetic screening shows that the production of oocytes is disrupted during fertility treatment involving ovarian stimulation...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
27 September 2012 • 1 minute read

IVF risks need to be highlighted and better reported, suggests editorial

by Dr Lucy Freem

Deaths related to IVF treatment should be better reported to stop them increasing, say the authors of a British Medical Journal (BMJ) editorial. The editorial argues IVF may be riskier than unassisted pregnancy or abortion, although deaths related to IVF remain rare...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
9 June 2009 • 2 minutes read

'No-drugs' IVF just as effective for under 35's

by Sarah Pritchard

By Sarah Guy; A new method of assisted conception has been hailed as a safer and equally effective alternative to IVF for certain groups of women undergoing treatment. The Oxford Fertility Centre revealed this week that of the 40 women they treated between February 2007 and March 2008 with in-vitro...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
9 June 2009 • 2 minutes read

Report triggers concerns over safety of fertility treatment in UK

by MacKenna Roberts

Fertility treatments performed in the UK are among the most risky in Europe, according to data released by the European Society for Human Reproduction and Embryology (ESHRE), reported in the Independent on Sunday. The chances of prospective mothers developing serious complications are reportedly four times greater than...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
9 June 2009 • 2 minutes read

Fertility experts recommend milder IVF treatment

by Dr Rachael Panizzo

By Rachael Dobson: A milder form of IVF treatment that has fewer side effects and is less expensive does not reduce the chances of a successful pregnancy, according to a new study. Research led by Dr Marinus Eijkemans, at Utrecht University Medical Centre in the Netherlands, reported that the milder...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Melanoma sequencing reveals genetic effects of sun damage

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

15 August 2022 • 2 minutes read

Call to end ban on HIV-positive partner gamete 'donation'

15 August 2022 • 2 minutes read

Melanoma invades new tissues using nerve cell gene

15 August 2022 • 2 minutes read

Exceeding alcohol limits could damage DNA and accelerate ageing

15 August 2022 • 2 minutes read

Blood cell gene mutations affect mitochondria, increasing cardiovascular disease risk

15 August 2022 • 2 minutes read

Jumping gene helps immune system fight viruses

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856